Research Topics
| Eline L KorenrompSummaryAffiliation: World Health Organization Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
Malaria attributable to the HIV-1 epidemic, sub-Saharan AfricaEline L Korenromp
World Health Organization, Geneva, Switzerland
Emerg Infect Dis 11:1410-9. 2005..These effects were due to high HIV-1 prevalence in rural areas and the locally unstable nature of malaria transmission that results in a high proportion of adult cases...
HIV dynamics and behaviour change as determinants of the impact of sexually transmitted disease treatment on HIV transmission in the context of the Rakai trialEline L Korenromp
Erasmus University Rotterdam, Department of Public Health, The Netherlands
AIDS 16:2209-18. 2002..To assess how the impact of sexually transmitted disease (STD) treatment on HIV incidence varies between stages of the HIV epidemic...- Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsyEline L Korenromp
Malaria Control Department of WHO, Geneva, Switzerland
Lancet Infect Dis 3:349-58. 2003.... - Impact of malaria control on childhood anaemia in Africa -- a quantitative reviewEline L Korenromp
World Health Organization, Roll Back Malaria, Geneva, Switzerland
Trop Med Int Health 9:1050-65. 2004..To review the impact of malaria control on haemoglobin (Hb) distributions and anaemia prevalences in children under 5 in malaria-endemic Africa... - HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populationsBrian G Williams
Stop TB Department, World Health Organization, Geneva 1211 CH 1211, Switzerland
J Infect Dis 194:1450-8. 2006.... - Implementing the global plan to stop TB, 2011-2015--optimizing allocations and the Global Fund's contribution: a scenario projections studyEline L Korenromp
Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland
PLoS ONE 7:e38816. 2012..We estimate the contribution and impact of Global Fund investments under various scenarios of allocations across interventions and regions... - Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative reviewEline L Korenromp
Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
PLoS ONE 4:e5950. 2009.... - What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic?Eline L Korenromp
Department of Public Health, Erasmus University Rotterdam, The Netherlands
Int J STD AIDS 13:91-101. 2002..In populations with low treatment rates like Uganda, these probabilities can be very low. Here, health education should have priority in STD management programmes... - Monitoring mosquito net coverage for malaria control in Africa: possession vs. use by children under 5 yearsEline L Korenromp
World Health Organization, Roll Back Malaria Monitoring and Evaluation, Geneva, Switzerland
Trop Med Int Health 8:693-703. 2003..To investigate the strengths and weaknesses of the indicators 'proportion of households possessing mosquito net(s)' and 'proportion of children under 5 years of age who slept under a net the preceding night' for monitoring malaria control... - Can behavior change explain increases in the proportion of genital ulcers attributable to herpes in sub-Saharan Africa? A simulation modeling studyEline L Korenromp
Department of Public Health, Faculty of Medicine, Erasmus University Rotterdam, P O Box 1738, 3000 DR Rotterdam, The Netherlands
Sex Transm Dis 29:228-38. 2002..The proportion of cases of genital ulcer disease attributable to herpes simplex virus type 2 (HSV-2) appears to be increasing in sub-Saharan Africa... - Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical reviewEline L Korenromp
Communicable Diseases, Stop TB Department, World Health Organization, Geneva, Switzerland
Clin Infect Dis 37:101-12. 2003..025). In countries where HIV infection is endemic, TB recurrence may be reduced by administration of rifampin-based treatment for at least 6 months, in accordance with World Health Organization recommendations... - Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortalityPhilippe Glaziou
World Health Organization, 20 avenue Appia 20, 1211 Geneva 27, Switzerland
Bull World Health Organ 89:573-82. 2011.... - Malaria risk: estimating clinical episodes of malariaBernard L Nahlen
World Health Organization, Roll Back Malaria Department, 1211 Geneva, Switzerland
Nature 437:E3; discussion E4-5. 2005..2). Both groups agree that the burden of malaria disease outside Africa, especially in South Asia, is greater than was estimated in the 1990s... - Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmissionNico J D Nagelkerke
Department of Public Health, Erasmus University Rotterdam, The Netherlands
Bull World Health Organ 80:89-96. 2002..To describe a dynamic compartmental simulation model for Botswana and India, developed to identify the best strategies for preventing spread of HIV/AIDS... - Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007Ryuichi Komatsu
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Chemin Blandonnet 8, 1214 Vernier, Geneva, Switzerland
BMC Infect Dis 10:109. 2010..This paper presents and discusses a methodology for estimating the lives saved through selected service deliveries reported to the Global Fund... - Progress towards malaria control targets in relation to national malaria programme fundingEline L Korenromp
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Malar J 12:18. 2013..This study assessed progress up to 2010 towards global malaria impact targets, in relation to Global Fund, other donor and domestic malaria programme financing over 2003 to 2009... - Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050Reuben Granich
HIV AIDS Department, World Health Organization, Geneva, Switzerland
PLoS ONE 7:e30216. 2012..Antiretroviral Treatment (ART) significantly reduces HIV transmission. We conducted a cost-effectiveness analysis of the impact of expanded ART in South Africa... - Reduced mortality with home-based HIV treatment in UgandaEline L Korenromp
Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva CH-1214, Switzerland
Lancet 371:703-5. 2008 - Quantifying HIV-1 transmission due to contaminated injectionsRichard G White
Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom
Proc Natl Acad Sci U S A 104:9794-9. 2007..This result is likely to be generalizable to many other populations in sub-Saharan Africa... - Estimating the number of insecticide-treated nets required by African households to reach continent-wide malaria coverage targetsJohn M Miller
PATH Malaria Control and Evaluation Partnership in Africa MACEPA, National Malaria Control Centre, Lusaka, Zambia
JAMA 297:2241-50. 2007..African countries are scaling up malaria interventions, especially insecticide-treated nets (ITNs), for which ambitious coverage targets have been set... - Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation resultsKate K Orroth
London School of Hygiene and Tropical Medicine, London, UK
Sex Transm Dis 33:536-44. 2006..Empirical PAF estimates from the Mwanza and Rakai trials indicated the proportion of HIV infections attributable to STDs was higher in Mwanza than Rakai... - The burden of malaria mortality among African children in the year 2000Alexander K Rowe
Malaria Branch, Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341 3724, USA
Int J Epidemiol 35:691-704. 2006..Our objective was to estimate the number of deaths directly attributable to malaria among children <5 years old in sub-Saharan Africa for the year 2000... - Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling studyRichard G White
London School of Hygiene and Tropical Medicine, London, UK
J Acquir Immune Defic Syndr 37:1500-13. 2004.... - Higher risk behaviour and rates of sexually transmitted diseases in Mwanza compared to Uganda may help explain HIV prevention trial outcomesKate K Orroth
London School of Hygiene and Tropical Medicine, London, UK
AIDS 17:2653-60. 2003.... - Child coverage with mosquito nets and malaria treatment from population-based surveys in african countries: a baseline for monitoring progress in roll back malariaRoeland Monasch
Division of Policy and Planning, United Nations Children's Fund, United Nations, New York, New York 10017, USA
Am J Trop Med Hyg 71:232-8. 2004..At the outset of intensified malaria control under Roll Back Malaria, coverage with principal interventions was far below the target of 60% set for Africa in 2005... - Pediatric mortality in Africa: plasmodium falciparum malaria as a cause or risk?Robert W Snow
Kenya Medical Research Institute Wellcome Trust Collaborative Program, Nairobi, Kenya
Am J Trop Med Hyg 71:16-24. 2004..In conclusion, the disability and death burden due to malaria in African children could be higher than that detectable from cause-specific DALY estimations... - The anatomy of a malaria disaster: drug policy choice and mortality in African childrenIan M Hastings
Molecular and Biochemical Parasitology, Liverpool School of Tropical Medicine, Liverpool, UK
Lancet Infect Dis 7:739-48. 2007..We show that parasitological failure is the most sensitive and timely indicator, which allows around 2-3 years for drug policy change to be implemented, so as to prevent the most rapid rise in malaria-related mortality...